Peptides

Tesamorelin

GHRH analogue for visceral fat reduction

GHRH Analogue — Purity >98% by HPLC

Lyophilized powder reconstituted in sterile aqueous solution

Scientific Composition

What is
Tesamorelin

Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH), FDA-approved for the treatment of abdominal lipodystrophy. It stimulates physiological pulsatile GH release by the pituitary, promoting significant reduction of visceral fat without the adverse effects associated with direct GH use. Clinical studies document up to 15% reduction in truncal fat over 26 weeks.

Documented reduction of abdominal visceral fat

Improvement in body composition and lipid profile

Physiological GH release without axis suppression

Ingredients

Formula Architecture

Lyophilized Tesamorelin

10mg

Physiological GHRH stimulation with visceral fat reduction

Sterile Solvent Solution

3ml

High-stability reconstitution

Usage Protocol

01
Reconstitute with the included sterile solvent
02
Mix gently until completely dissolved
03
Apply as directed by a specialized professional
04
Keep refrigerated (2–8°C) after reconstitution

Clinical Evidence